Price $2.85 |
Market Cap
519.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.95
|
P/S
1.64
|
Dividend %
-
|
|
P/CF
5.8
|
P/FCF
-
|
Op. Cash Flow
-110.4K
|
FCF
-
|
|
Op. Margin
-127.50%
|
Net Margin
-129.90%
|
ROE
-115.10%
|
ROI
-109.40%
|
|
ROA
-53.80%
|
EPS Growth
-17.50%
|
Current Ratio
2.0
|
Debt/Equity
38.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ImmuCell Corporation (ICCC) | $8.50 | - | - | 69.5M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $5.68 | - | - | 2.02B | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $65.60 | - | 3.10% | 141.03B | Strong Buy |
| AEterna Zentaris Inc. (USA) (AEZS) | $0.91 | - | - | 133.3M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $6.83 | - | - | 217.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
